Evidence map›Paper›PMID 19109199›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis.

Philip L Simonian, Christina L Roark, Fabian Wehrmann, Allison K Lanham, Fernando Diaz del Valle, Willi K Born, Rebecca L O'Brien, Andrew P Fontenot

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 2 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. How experimental models have unlocked hidden mechanisms of hypersensitivity pneumonitis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  4. Frontiers in medicine · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Differential Immunogenicity and Lung Disease-Inducing Potential ofInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Muc5b plays a role in the development of inflammation and fibrosis in hypersensitivity pneumonitis induced byAmerican journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Philip L SimonianDepartment of Medicine, University of Colorado Denver, Denver, CO 80262, USA. philip.simonian@ucdenver.edu
Christina L Roark
Fabian Wehrmann
Allison K Lanham
Fernando Diaz del Valle
Willi K Born
Rebecca L O'Brien
Andrew P Fontenot
National Jewish Health · USUniversity of Denver · USUniversity of Colorado Denver · US

Funding

T Cells in Beryllium Sensitization and DiseaseP01ES011810 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI NEWMAN, LEE S · 2002 to 2013
$14.0M
PATHOGENIC T CELLS IN CHRONIC BERYLLIUM DISEASER01HL062410 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 1998 to 2017
$5.7M
Regulatory Role of Gama-Delta T cells in the Development of Pulmonary FibrosisK08HL089766 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SIMONIAN, PHILIP LEVON · 2007 to 2011
$662k
NHLBI NIH HHS HL62410NHLBI NIH HHS HL89766NHLBI NIH HHS K08 HL089766NHLBI NIH HHS R01 HL062410NIEHS NIH HHS ES011810NIEHS NIH HHS P01 ES011810
6 · The paper itself

Abstract

Hypersensitivity pneumonitis is an environmental lung disease characterized by a diffuse mononuclear cell infiltrate in the lung that can progress to pulmonary fibrosis with chronic exposure to an inhaled Ag. Using a well-established murine model of hypersensitivity pneumonitis, we repeatedly exposed C57BL/6 mice to Saccharopolyspora rectivirgula to investigate whether T cells are required for lung fibrosis. In the absence of alphabeta T cells, TCRbeta(-/-) mice exposed to S. rectivirgula for 4 wk had markedly decreased mononuclear infiltrates and collagen deposition in the lung compared with wild-type C57BL/6 mice. In contrast to CD8(+) T cells, adoptive transfer of CD4(+) T cells reconstituted the S. rectivirgula-induced inflammatory and fibrotic response, suggesting that the CD4(+) T cell represents the critical alphabeta T cell subset. Cytokine analysis of lung homogenates at various time points after S. rectivirgula exposure failed to identify a predominant Th1 or Th2 phenotype. Conversely, IL-17 was found in the lung at increasing concentrations with continued exposure to S. rectivirgula. Intracellular cytokine staining revealed that 14% of CD4(+) T cells from the lung of mice treated with S. rectivirgula expressed IL-17A. In the absence of IL-17 receptor signaling, Il17ra(-/-) mice had significantly decreased lung inflammation and fibrosis compared with wild-type C57BL/6 mice. These data are the first to demonstrate an important role for Th17-polarized CD4(+) T lymphocytes in the immune response directed against S. rectivirgula in this murine model of hypersensitivity pneumonitis and pulmonary fibrosis.

Indexed as

Adoptive TransferAlveolitis, Extrinsic AllergicAnimalsDisease Models, AnimalFarmer's LungFemaleImmunophenotypingInterleukin-17MiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPulmonary FibrosisReceptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, gamma-deltaSaccharopolysporaIl17a protein, mouseInterleukin-17Receptors, Antigen, T-Cell, alpha-betaReceptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID19109199
PMCPMC2766086
OpenAlexW1641604213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.